Dr. Corbau's appointment, with his gene therapy expertise, i...

Dr. Corbau's appointment, with his gene therapy expertise, is seen as crucial for Adverum's Ixo-vec advancement towards pivotal trials and commercialization for treating wet AMD. He is eager to progress Adverum's early-stage research assets and sees Ixo-vec as a potential leading therapy for wet AMD.